Skip to main content
Top
Published in: General Thoracic and Cardiovascular Surgery 12/2017

01-12-2017 | Original Article

Clinical outcomes of aortic repair in young adult patients with ACTA2 mutations

Authors: Yoshimasa Seike, Kenji Minatoya, Hiroaki Sasaki, Hiroshi Tanaka, Tatsuya Itonaga, Yosuke Inoue, Hiroko Morisaki, Takayuki Morisaki, Hatsue Ishibashi-Ueda, Junjiro Kobayashi

Published in: General Thoracic and Cardiovascular Surgery | Issue 12/2017

Login to get access

Abstract

Objectives

Actin, alpha-2, smooth muscle, aorta (ACTA2) mutations are one of the major causes of familial thoracic aortic aneurysms and dissections. The aim of this study was to review our clinical results of young adult patients with aortic disease caused by ACTA2 mutations.

Methods

We reviewed the medical records of 251 patients (<50 years old) who underwent surgery for thoracic aortic diseases between 2004 and 2014. Among them, nine patients (3.5%) had ACTA2 mutations. Their average age was 35 years (range 22–47) and two patients (22.2%) were males. No patients fulfilled the diagnostic criteria for Marfan syndrome. Preoperative diagnoses included annulo-aortic ectasia (n = 2), localized dissection of the sinus of Valsalva (n = 2), acute type B aortic dissection (n = 1), and chronic type B (n = 4). Eight patients (88.9%) had hypertension.

Results

A thoracoabdominal aortic replacement was required in three patients who had descending replacement for residual chronic type B aortic dissection. A patient who had thoracic endovascular aortic repair for complicated acute type B aortic dissection showed no aortic dilatation for 7 years after TEVAR. Histological results revealed cystic medial necrosis (CMN) in most cases (7/8; 87.5%).

Conclusion

Surgical outcomes for patients with ACTA2 mutations were satisfactory. CMN was a major histological finding and family history of aortic event was detected in only half of the patients with ACTA2 mutations. Despite no characteristic physical findings besides hypertension, connective tissue disease including ACTA2 mutations should be considered for aortic dissection in young adult patients.
Literature
1.
go back to reference Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–9.CrossRefPubMed Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–9.CrossRefPubMed
2.
go back to reference Regalado ES, Guo DC, Prakash S, Bensend TA, Flynn K, Estrera A, et al. Aortic disease presentation and outcome associated with ACTA2 mutations. Circ Cardiovasc Genet. 2015;8:457–64.CrossRefPubMedPubMedCentral Regalado ES, Guo DC, Prakash S, Bensend TA, Flynn K, Estrera A, et al. Aortic disease presentation and outcome associated with ACTA2 mutations. Circ Cardiovasc Genet. 2015;8:457–64.CrossRefPubMedPubMedCentral
3.
go back to reference Morisaki H, Akutsu K, Ogino H, Kondo N, Yamanaka I, Tsutsumi Y, et al. Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD). Hum Mutat. 2009;30:1406–11.CrossRefPubMed Morisaki H, Akutsu K, Ogino H, Kondo N, Yamanaka I, Tsutsumi Y, et al. Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD). Hum Mutat. 2009;30:1406–11.CrossRefPubMed
4.
go back to reference Pomianowski P, Elefteriades JA. The genetics and genomics of thoracic aortic disease. Ann Cardiothorac Surg. 2013;2:271–9.PubMedPubMedCentral Pomianowski P, Elefteriades JA. The genetics and genomics of thoracic aortic disease. Ann Cardiothorac Surg. 2013;2:271–9.PubMedPubMedCentral
5.
go back to reference Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, Bourgeois S, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007;39:1488–93.CrossRefPubMed Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, Bourgeois S, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007;39:1488–93.CrossRefPubMed
6.
go back to reference Germain DP. Clinical and genetic features of vascular Ehlers–Danlos syndrome. Ann Vasc Surg. 2002;16:391–7.CrossRefPubMed Germain DP. Clinical and genetic features of vascular Ehlers–Danlos syndrome. Ann Vasc Surg. 2002;16:391–7.CrossRefPubMed
7.
go back to reference Seike Y, Minatoya K, Sasaki H, Tanaka H. Recurrent aortic regurgitation after valve-sparing aortic root replacement due to dilatation of a previously implanted Valsalva graft. Interact Cardiovasc Thorac Surg. 2016;22:241–2.CrossRefPubMed Seike Y, Minatoya K, Sasaki H, Tanaka H. Recurrent aortic regurgitation after valve-sparing aortic root replacement due to dilatation of a previously implanted Valsalva graft. Interact Cardiovasc Thorac Surg. 2016;22:241–2.CrossRefPubMed
8.
go back to reference Schlatmann TJ, Becker AE. Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am J Cardiol. 1977;39:13–20.CrossRefPubMed Schlatmann TJ, Becker AE. Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am J Cardiol. 1977;39:13–20.CrossRefPubMed
9.
go back to reference Attias D, Stheneur C, Roy C, Collod-Beroud G, Detaint D, Faivre L, et al. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation. 2009;120:2541–9.CrossRefPubMed Attias D, Stheneur C, Roy C, Collod-Beroud G, Detaint D, Faivre L, et al. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation. 2009;120:2541–9.CrossRefPubMed
10.
go back to reference Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1960;1995(26):60–9. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1960;1995(26):60–9.
11.
go back to reference LeMaire SA, Russell L. Epidemiology of thoracic aortic dissection. Nat Rev Cardiol. 2011;8:103–13.CrossRefPubMed LeMaire SA, Russell L. Epidemiology of thoracic aortic dissection. Nat Rev Cardiol. 2011;8:103–13.CrossRefPubMed
12.
go back to reference Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd. Angiotensin II brockade and aortic-root dilation in Marfan’s syndrome. N Eng J Med. 2008;358:2787–95.CrossRef Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd. Angiotensin II brockade and aortic-root dilation in Marfan’s syndrome. N Eng J Med. 2008;358:2787–95.CrossRef
13.
go back to reference Franken R, den Hartog AW, Radonic T, Micha D, Maugeri A, van Dijk FS, et al. Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome. Circ Cardiovasc Genet. 2015;8:383–8.CrossRefPubMed Franken R, den Hartog AW, Radonic T, Micha D, Maugeri A, van Dijk FS, et al. Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome. Circ Cardiovasc Genet. 2015;8:383–8.CrossRefPubMed
14.
go back to reference Regalado ES, Guo DC, Estrera AL, Buja LM, Milewicz DM. Acute aortic dissections with pregnancy in women with ACTA2 mutations. Am J Med Genet A. 2014;64:106–12.CrossRef Regalado ES, Guo DC, Estrera AL, Buja LM, Milewicz DM. Acute aortic dissections with pregnancy in women with ACTA2 mutations. Am J Med Genet A. 2014;64:106–12.CrossRef
15.
go back to reference Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F, Dietz HC. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of marfan syndrome. Circ Res. 2001;88:37–43.CrossRefPubMed Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F, Dietz HC. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of marfan syndrome. Circ Res. 2001;88:37–43.CrossRefPubMed
16.
go back to reference Girdauskas E, Kuntze T, Borger MA, Doenst T, Mochalski M, Walther T, et al. Long-term prognosis of type A aortic dissection in non-Marfan patients with histologic pattern of cystic medial necrosis. Ann Thorac Surg. 2008;85:972–7.CrossRefPubMed Girdauskas E, Kuntze T, Borger MA, Doenst T, Mochalski M, Walther T, et al. Long-term prognosis of type A aortic dissection in non-Marfan patients with histologic pattern of cystic medial necrosis. Ann Thorac Surg. 2008;85:972–7.CrossRefPubMed
17.
go back to reference Ueda T, Shimizu H, Aeba R, Shin H, Katogi T, Yozu R, et al. Prognosis of Marfan and non-Marfan patients with cystic medial necrosis of the aorta. Jpn J Thorac Cardiovasc Surg. 1999;47:73–8.CrossRefPubMed Ueda T, Shimizu H, Aeba R, Shin H, Katogi T, Yozu R, et al. Prognosis of Marfan and non-Marfan patients with cystic medial necrosis of the aorta. Jpn J Thorac Cardiovasc Surg. 1999;47:73–8.CrossRefPubMed
Metadata
Title
Clinical outcomes of aortic repair in young adult patients with ACTA2 mutations
Authors
Yoshimasa Seike
Kenji Minatoya
Hiroaki Sasaki
Hiroshi Tanaka
Tatsuya Itonaga
Yosuke Inoue
Hiroko Morisaki
Takayuki Morisaki
Hatsue Ishibashi-Ueda
Junjiro Kobayashi
Publication date
01-12-2017
Publisher
Springer Japan
Published in
General Thoracic and Cardiovascular Surgery / Issue 12/2017
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-017-0810-0

Other articles of this Issue 12/2017

General Thoracic and Cardiovascular Surgery 12/2017 Go to the issue